Name: 글로벌 시장 동향
SKU: BT7819
Availability: InStock

보고서 요약(국문)

개요
글로벌 단일 세포 오믹스 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
오믹스는 유전체학, 전사체학, 단백체학, 지질체학, 대사체학을 포함한 다양한 분자 분석을 포괄합니다. 전사체학은 전체 조직 또는 장기의 유전자 발현 패턴을 분석합니다. 단일 세포 분리 기술과 더욱 민감한 분자 기술의 발전으로 이제 단일 세포 수준에서 오믹스 분석을 수행할 수 있게 되었으며, 이를 통해 조직 전반에 걸친 세포의 이질성에 대한 독특한 통찰력을 얻을 수 있습니다.
시장 동향: 성장 동인 및 제약 요인
맞춤형 의약품에 대한 수요 증가
단일 세포 오믹스 시장의 성장을 견인하는 여러 요인 중 하나는 맞춤형 의약품에 대한 수요 증가입니다. 분자 수준에서 개별 세포를 분석하면 질병의 근본적인 메커니즘에 대한 귀중한 통찰력을 얻을 수 있으며, 이를 통해 더욱 정밀하고 맞춤화된 치료가 가능해집니다. 또한, 급속한 기술 발전으로 단일 세포 오믹스 분석이 더욱 접근하기 쉽고 비용 효율적으로 변모했습니다.
예를 들어, 2021년 6월 SCIENION과 Cellenion은 단일 세포 오믹스 샘플 준비를 위한 cellenCHIP 384를 출시한다고 발표했으며, 이를 확장 가능한 나노리터 용량의 단일 세포 라이브러리 준비를 위한 새로운 cellenCHIP 384 – 3’RNA-seq 키트의 필수 소모품으로 소개했습니다.
나노웰 포맷, 다양한 액세서리 및 맞춤 설정 옵션을 갖춘 cellenCHIP 384는 소형화 및 고처리량 워크플로우를 위한 cellenONE의 자동화 기능을 더욱 확장합니다. 단일 세포 오믹스 분석은 정밀 의학 분야에서 삶을 변화시키는 발전을 가져오며, 종양학 등의 분야에서 분석물 프로파일링 가능성을 크게 향상시킵니다.
더 나아가, 제약 및 생명공학 기업과 연구 기관 간의 다양한 협력 및 공동 연구가 증가하고 있으며, 이는 시장 성장을 더욱 촉진하는 중요한 역할을 합니다.

시장 동향: 제약 요인
안전 문제는 예측 기간 동안 시장 성장을 저해하는 제약 요인 중 하나입니다. 단일 세포 오믹스 기술의 사용은 개인 정보 보호, 사전 동의, 데이터 오용 가능성과 관련된 윤리적 문제를 제기합니다. 이러한 문제들을 해결하여 해당 분야에서 책임 있는 사용과 윤리적 관행을 보장해야 합니다.
세분화 분석
글로벌 단일 세포 오믹스 시장은 제품 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 단일 세포 유전체학은 단일 세포 오믹스 시장 점유율의 약 41.5%를 차지했습니다.
제품 유형 부문에서 단일 세포 유전체학은 약 41.5%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 단일 세포 유전체학은 오믹스 접근 방식을 사용하여 세포의 개별성을 연구하는 분야입니다. 이 분야는 아직 역사가 짧지만, 이제 성숙기에 접어들고 뚜렷한 발전 징후를 보이고 있습니다. 그 기원은 마이크로어레이를 통해 단일 세포에서 유전자 발현을 검출할 수 있게 해준 선구적인 실험으로 거슬러 올라갑니다.
다양한 최종 사용자의 수요 증가, 단일 세포 유전체학 플랫폼의 잠재적인 임상 적용, 그리고 기술 발전과 같은 요인들이 해당 부문의 성장을 이끄는 주요 원동력입니다.
예를 들어, 2023년 1월, 게놈 과학 핵심 시설은 단일 세포 멀티오믹스 및 공간 전사체학을 포함한 최첨단 기술을 이용할 수 있다고 발표했습니다. 10x Genomics Chromium 컨트롤러를 사용하는 단일 세포 유전체학의 경우, 단일 샘플에서 최대 10,000개의 세포를 분석할 수 있습니다. 공간 전사체학의 경우, Visium 공간 유전자 발현 서비스는 포르말린 고정 파라핀 포매(FFPE) 조직과 신선 냉동 조직 모두에서 제공됩니다.

또한, 고처리량 단일 세포 DNA 및 멀티오믹스 분석 분야의 선구자인 미션 바이오(Mission Bio, Inc.)는 2022년 3월, 고형암 연구를 위한 최초의 단일 세포 유전체학 고형암 솔루션을 태피스트리(Tapestri) 플랫폼에서 출시했습니다. 태피스트리 플랫폼 기반의 이 새로운 엔드투엔드 단일 세포 DNA 시퀀싱 워크플로우에는 핵 분리 준비 프로토콜, 유방암 및 교모세포종 사전 설계 연구 패널, 그리고 개선된 단일 세포 유전자 복제 수 변이(CNV) 생물정보학 분석 도구가 포함됩니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 우수한 대학, 연구 기관 및 제약 회사를 포함한 잘 구축된 연구 개발 인프라와 기업의 확장, 지속적인 연구 개발로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.

예를 들어, 조합 인덱싱 기술을 활용한 단일 세포 시퀀싱 분야의 혁신 기업인 스케일 바이오사이언스(Scale Biosciences, Inc.)는 2023년 8월, 더 광범위한 단일 세포 오믹스 실험을 가능하게 하고 새로운 중개 연구 응용 분야를 개척하기 위해 제품 포트폴리오 확장에 착수했습니다.
또한, 단일 세포 시퀀싱 및 조합 인덱싱 기술의 선구자인 스케일 바이오사이언스(ScaleBio)는 2022년 12월, 1세대 단일 세포 전사체 scRNAseq 프로파일링 및 분석 솔루션을 출시하며 연구 개발 단계에서 상용화 단계로 전환하여 접근성, 확장성, 저비용 단일 세포 시퀀싱의 새로운 기준을 제시했습니다.

COVID-19 영향 분석
COVID-19는 바이러스-숙주 상호작용, 면역 반응, 다양한 세포 유형에 대한 바이러스의 영향 등을 연구하는 데 이 기술에 대한 수요가 급증함에 따라 시장에 긍정적인 영향을 미쳤습니다. 또한, 이 기술은 특정 마커를 연구하여 정밀 진단법을 개발하는 데에도 활용되었습니다.

시장 세분화
제품 유형별
• 단일 세포 유전체학
• 단일 세포 단백체학
• 단일 세포 대사체학
• 단일 세포 전사체학
응용 분야별
• 종양학
• 세포 생물학
• 신경학
• 면역학
• 기타
최종 사용자별
• 제약 및 생명공학 회사
• 학술 및 연구 기관
• 병원 및 진단 실험실
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 CYTENA GmbH, 10x Genomics, Becton, Dickinson and Company, CELLENION 등이 있습니다. Bio-Rad Laboratories Inc, Mission Bio, Standard BioTools Inc, Nanostring, Takarabio, BGI Genomics Co 등을 포함한 여러 기업이 주요 기업입니다.

주요 개발 사항
 차세대 시퀀싱(NGS) 및 멀티오믹스 기술을 활용하여 연구자와 임상의에게 혁신적인 솔루션을 제공하는 Singular Genomics Systems, Inc.는 2023년 2월, AGBT(Advances in Genome Biology and Technology) 제23차 총회에서 자사의 G4 시퀀싱 플랫폼 기반 단일 세포 분석용 Max Read Kits를 출시한다고 발표했습니다.

보고서 구매 이유

• 제품 유형, 응용 분야, 최종 사용자 및 지역별 글로벌 단일 세포 오믹스 시장 세분화 현황을 시각화하고 주요 기업 및 주요 사업자를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 단일 세포 오믹스 시장 수준의 다양한 데이터가 담긴 Excel 파일입니다.

• PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 자료로 구성됩니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료는 엑셀 파일로 제공됩니다.
글로벌 단일 세포 오믹스 시장 보고서는 약 61개의 표, 58개의 그림, 187페이지 분량입니다.
2023년 주요 독자층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Single Cell Omics Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Omics encompasses various molecular analyses, including genomics, transcriptomics, proteomics, lipidomics, and metabolomics. Transcriptomics analyzes gene expression patterns across whole tissues or organs. With emerging technologies in single-cell isolation and more sensitive molecular technologies, omics analyses can now be conducted at single-cell resolution, providing unique insights into the heterogeneity of cells across tissues.
Market Dynamics: Drivers and Restraints
Increasing demand for personalized medicines
Several factors are driving the growth of the single-cell omics market one of the major drivers is the increasing demand for personalized medicine. Analyzing individual cells at a molecular level can provide valuable insights into the underlying disease mechanisms, leading to more precise and customized treatments. Also, rapid technological advancements have made single-cell omics more accessible and cost-effective.
For instance, in June 2021, SCIENION and Cellenion announced the launch of the cellenCHIP 384 for single-cell omics sample preparation, introducing it as the integral consumable in the new cellenCHIP 384 – 3’RNA-seq Kit for scalable, nanoliter volume library preparation of single cells.
The cellenCHIP 384, with its nano well format, accessory range and options for customization, further extends the automated capabilities of the cellenONE for miniaturization and high throughput workflows. Single-cell omics lead to life-changing advances in precision medicine and the technologies greatly enhance analyte profiling possibilities in fields such as oncology.
Furthermore, an increase in various initiatives and collaborations among pharmaceutical and biotechnological companies and research institutes play a pivotal role and thus, further boost the market growth.
Market Dynamics: Restraint
Safety concerns are one of the restraint factors that hamper the market growth during the forecast period. The use of single-cell omics technologies raises ethical concerns related to privacy, informed consent, and the potential misuse of data. These issues need to be addressed to ensure responsible use and ethical practices in the field.
Segment Analysis
The global single-cell omics market is segmented based on product type, application, end-user and region.
The single-cell genomics from the product type segment accounted for approximately 41.5% of the single-cell omics market share
The single cell genomics from the product type segment accounted for approximately 41.5% and it is expected to be dominated during the forecast period. Single-cell genomics is the study of the individuality of cells using omics approaches. Although young, the field has now entered its teenage years and is beginning to show clear signs of maturity. Its origins can be traced back to pioneering experiments that allowed the detection of gene expression in single cells by microarrays.
Factors such as increasing demand from a wide range of end-users, potential clinical applications of single-cell genomics platforms, and technological advancements are the major factors driving segment growth.
For instance, in January 2023, the Genome Sciences core facility stated that leading-edge technologies, including single-cell multiomics and spatial transcriptomics, are now available. For single-cell genomics using the 10x Genomics Chromium controller, up to 10,000 cells can be captured in a single sample. For spatial transcriptomics, Visium spatial gene expression services are offered both in formalin-fixed paraffin-embedded (FFPE) and fresh frozen tissues.
Moreover, in March 2022, Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, launched the first-in-class single-cell genomics solid tumor solution on the tapestri platform for solid tumor research. This new end-to-end single-cell DNA sequencing workflow on the Tapestri Platform includes nuclei isolation prep protocol, pre-designed research panels for breast cancer and glioblastoma multiforme, and an improved single-cell copy number variation (CNV) bioinformatic analysis tool.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the well-established research and development infrastructure, including top universities, research institutions, and pharmaceutical companies, companies’ expansion, ongoing research and development will further drive this region to have highest market share.
For instance, in August 2023, Scale Biosciences, Inc. an innovator in single-cell sequencing leveraging combinatorial indexing technologies, started an expansion of their product portfolio to enable a broader range of single-cell omics experiments and unlock new translational research applications.
Moreover, in December 2022, Scale Biosciences, Inc. (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, transitioned from research and development to the commercial stage with the release of its first generation single-cell transcriptomics scRNAseq profiling and analysis solution, establishing new standards for accessible, scalable, and low-cost single-cell sequencing.
COVID-19 Impact Analysis
COVID-19 had a positive impact on the market as this technology was in high demand to investigate the viral-host interactions, immune response, and the effects of the virus on various cell types. In addition, technology has been used in developing precision diagnostics by studying specific markers.
Market Segmentation
By Product Type
• Single-cell Genomics
• Single-cell Proteomics
• Single-cell Metabolomics
• Single-cell Transcriptomics
By Application
• Oncology
• Cell Biology
• Neurology
• Immunology
• Others
By End User
• Pharmaceutical & Biotechnology companies
• Academic and Research Organizations
• Hospitals and Diagnostic laboratories
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include CYTENA GmbH, 10x Genomics, Becton, Dickinson and Company, CELLENION, Bio-Rad Laboratories Inc, Mission Bio, Standard BioTools Inc, Nanostring, Takarabio, BGI Genomics Co and among others.
Key Developments
 In February 2023, Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, stated the launch of its Max Read Kits for single-cell applications on the company’s G4 Sequencing Platform at the Advances in Genome Biology and Technology (AGBT) 23rd General Meeting.
Why Purchase the Report?
• To visualize the global single-cell omics market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of single-cell omics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global single-cell omics market report would provide approximately 61 tables, 58 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing demand for precision medicines
4.1.1.2. Rise in the prevalence of cancers
4.1.2. Restraints
4.1.2.1. Safety concerns
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Single-cell Genomics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Single-cell Proteomics
7.4. Single-cell Metabolomics
7.5. Single-cell Transcriptomics
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Oncology*
8.2.1. Introduction
8.3. Cell biology
8.4. Neurology
8.5. Immunology
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Pharmaceutical & Biotechnology companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic and Research Organizations
9.4. Hospitals and Diagnostic Laboratories
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.5.1. Germany
10.3.5.2. UK
10.3.5.3. France
10.3.5.4. Italy
10.3.5.5. Spain
10.3.5.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.5.1. Brazil
10.4.5.2. Argentina
10.4.5.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.4.1. China
10.5.4.2. India
10.5.4.3. Japan
10.5.4.4. Australia
10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. CYTENA GmbH *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. 10x Genomics
12.3. Becton, Dickinson and Company
12.4. CELLENION
12.5. Bio-Rad Laboratories Inc
12.6. Mission Bio
12.7. Standard BioTools Inc
12.8. Nanostring
12.9. Takarabio
12.10. BGI Genomics Co
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

CYTENA GmbH, 4.	Key Developments, 10x Genomics, Becton, Dickinson and Company, CELLENION, Bio-Rad Laboratories Inc, Mission Bio, Standard BioTools Inc, Nanostring, Takarabio, BGI Genomics Co

표 목록 (Tables)

List of Tables

Table 1 Global Single Cell Omics Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Single Cell Omics Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Single Cell Omics Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Single Cell Omics Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Single Cell Omics Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Single Cell Omics Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Single Cell Omics Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Single Cell Omics Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Single Cell Omics Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Single Cell Omics Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Single Cell Omics Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Single Cell Omics Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Single Cell Omics Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Single Cell Omics Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Single Cell Omics Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Single Cell Omics Market Value, By End User, 2022-2031 (US$ Million)

Table 32 CYTENA GmbH: Overview

Table 33 CYTENA GmbH: Product Portfolio

Table 34 CYTENA GmbH: Key Developments

Table 35 10x Genomics: Overview

Table 36 10x Genomics: Product Portfolio

Table 37 10x Genomics: Key Developments

Table 38 Becton, Dickinson and Company: Overview

Table 39 Becton, Dickinson and Company: Product Portfolio

Table 40 Becton, Dickinson and Company: Key Developments

Table 41 CELLENION: Overview

Table 42 CELLENION: Product Portfolio

Table 43 CELLENION: Key Developments

Table 44 Bio-Rad Laboratories Inc: Overview

Table 45 Bio-Rad Laboratories Inc: Product Portfolio

Table 46 Bio-Rad Laboratories Inc: Key Developments

Table 47 Mission Bio: Overview

Table 48 Mission Bio: Product Portfolio

Table 49 Mission Bio: Key Developments

Table 50 Standard BioTools Inc: Overview

Table 51 Standard BioTools Inc: Product Portfolio

Table 52 Standard BioTools Inc: Key Developments

Table 53 Nanostring: Overview

Table 54 Nanostring: Product Portfolio

Table 55 Nanostring: Key Developments

Table 56 Takarabio: Overview

Table 57 Takarabio: Product Portfolio

Table 58 Takarabio: Key Developments

Table 59 BGI Genomics Co: Overview

Table 60 BGI Genomics Co: Product Portfolio

Table 61 BGI Genomics Co: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 2 Global Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Single Cell Omics Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Single Cell Omics Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 7 Single-cell Genomics Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 8 Single-cell Proteomics Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 9 Single-cell Metabolomics Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 10 Single-cell Transcriptomics Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 11 Global Single Cell Omics Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 12 Oncology Application in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 13 Cell biology Application in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 14 Neurology Application in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 15 Immunology Application in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 16 Others Application in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 17 Global Single Cell Omics Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 18 Pharmaceutical & Biotechnology companies End User in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 19 Academic and Research Organizations End User in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 20 Hospitals and Diagnostic laboratories End User in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 21 Others End User in Global Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 22 Global Single Cell Omics Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 24 Asia-Pacific Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 25 Europe Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 26 South America Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 27 Middle East and Africa Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 28 North America Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 29 North America Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 30 North America Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 31 North America Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 32 North America Single Cell Omics Market Share, By Country, 2022 & 2031 (%)

Figure 33 South America Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 34 South America Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 35 South America Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 36 South America Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 37 South America Single Cell Omics Market Share, By Country, 2022 & 2031 (%)

Figure 38 Europe Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 39 Europe Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 40 Europe Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 41 Europe Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 42 Europe Single Cell Omics Market Share, By Country, 2022 & 2031 (%)

Figure 43 Asia-Pacific Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 44 Asia-Pacific Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 45 Asia-Pacific Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 46 Asia-Pacific Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 47 Asia-Pacific Single Cell Omics Market Share, By Country, 2022 & 2031 (%)

Figure 48 Middle East & Africa Single Cell Omics Market Value, 2022-2031 (US$ Million)

Figure 49 Middle East & Africa Single Cell Omics Market Share, By Product Type, 2022 & 2031 (%)

Figure 50 Middle East & Africa Single Cell Omics Market Share, By Application, 2022 & 2031 (%)

Figure 51 Middle East & Africa Single Cell Omics Market Share, By End User, 2022 & 2031 (%)

Figure 52 CYTENA GmbH: Financials

Figure 53 10x Genomics: Financials

Figure 54 Becton, Dickinson and Company: Financials

Figure 55 CELLENION: Financials

Figure 56 Bio-Rad Laboratories Inc: Financials

Figure 57 Mission Bio: Financials

Figure 58 Standard BioTools Inc: Financials

Figure 59 Nanostring: Financials

Figure 60 Takarabio: Financials

Figure 61 BGI Genomics Co: Financials

글로벌 단일 세포 오믹스 시장 – 2023-2030

Global Single-cell Omics Market - 2023-2030